Oncolytics Biotech, Inc. (ONCY)
1.04
+0.10
(+11.23%)
USD |
NASDAQ |
May 29, 16:00
1.07
+0.03
(+2.88%)
After-Hours: 20:00
Oncolytics Biotech Total Liabilities (Quarterly) : 13.29M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Replimune Group, Inc. | 123.05M |
| Arrowhead Pharmaceuticals, Inc. | 1.669B |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.674B |
| Anixa Biosciences, Inc. | 1.387M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.161M |
| Shareholders Equity (Quarterly) | -5.13M |
| Debt to Equity Ratio | -0.099 |
| Current Ratio | 1.381 |
| Net Debt Paydown Yield | 0.05% |